Fludarabine (Fludara®) Plus Alemtuzumab (CAMPATH®, MabCampath®) vs Fludarabine Alone in B-Cell Chronic Lymphocytic Leukemia (B-CLL) Patients

NCT00086580 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

335

Enrollment

INDUSTRY

Sponsor class

Conditions

B-Cell Chronic Lymphocytic Leukemia

Interventions

BIOLOGICAL: FluCAM [Fludara + Campath]
BIOLOGICAL: fludarabine phosphate

Sponsor

Genzyme, a Sanofi Company